Targeting the activin receptor signaling to counteract the multi-systemic complications of cancer and its treatments

HIGHLIGHTS

• who: Juha J. Hulmi and colleagues from the Faculty of Sport and Health Sciences, NeuroMuscular Research Center, University of Jyväskylä, Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA have published the research work: Targeting the Activin Receptor Signaling to Counteract the Multi-Systemic Complications of Cancer and Its Treatments, in the Journal: Cells 2021, x of /2021/
• what: The authors aim to provide an up-to-date literature review on the multifaceted anti-cachectic effects of ACVR2 blockade in preclinical models of cancer as well as in combination with anticancer treatments . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.